They are submitting an IND, which is great but they still have Phase 1, 2 and 3 to go. It's also a cell therapy so if it works, it's likely to be quite expensiv

They are submitting an IND, which is great but they still have Phase 1, 2 and 3 to go. It's also a cell therapy so if it works, it's likely to be quite expensive to receive. That said, if it works, it's a wonderful breakthrough that will hopefully spur others.